Prospective Breast Cancer Biospecimen Collection

Launched by THOMAS JEFFERSON UNIVERSITY · Aug 27, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on collecting samples from patients with breast cancer to better understand the disease. If you are an adult over 18 and have been diagnosed with either invasive breast cancer or carcinoma in situ (a non-invasive form of breast cancer), you may be eligible to participate. The trial is currently recruiting participants who are scheduled for certain procedures, such as surgery to remove a tumor or placement of a device to help with treatment.

If you join the trial, during your scheduled procedure, a small blood sample will be taken, and there may also be an optional swab from the rectum to analyze the bacteria present. This is a one-time participation, and the follow-up will involve reviewing your medical records to track any changes in your condition, such as recurrence of cancer or spread to other areas. It's important to know that the trial excludes anyone under 18 or those who cannot provide consent themselves. If you meet the criteria and are interested, this study could contribute to important research on breast cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults \>18 years old at time of consent
• • Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
• • Patients with carcinoma in situ or invasive breast cancer
• * Patient must be undergoing one of the following:
• • definitive surgical tumor resection for breast cancer OR
• • placement of a vascular access device as a prelude to neoadjuvant therapy for breast cancer OR
• • neurosurgical resection of a brain metastasis from primary breast cancer.
• Exclusion Criteria:
• • \<18 years old
• • Not able to give informed consent and does not have acceptable surrogate capable to giving informed consent.
• • Active drug/alcohol dependence or abuse history